Equillium, Inc.
EQ- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001746466
No open-market purchases or sales by Equillium, Inc. insiders were filed in the last 90 days; 60 institutions reported holding it in 13F filings for Q2 2026, worth $133.0M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Equillium, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- +4 vs. Q3 2021
- Shares held
- 7.19M
- −131.9K (−1.8%) vs. Q3 2021
- Total value
- $27.0M
- −$22.9M (−45.9%) vs. Q3 2021
- New holders
- 7
- 4 more added
- Sold out
- 3
- 6 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EQ on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 60 | $133.0M |
| Q1 2026 | 50 | $81.0M |
| Q4 2025 | 36 | $54.7M |
| Q3 2025 | 40 | $42.4M |
| Q2 2025 | 27 | $2.74M |
| Q1 2025 | 24 | $3.39M |
| Q4 2024 | 26 | $6.52M |
| Q3 2024 | 26 | $7.25M |
| Q2 2024 | 25 | $6.15M |
| Q1 2024 | 28 | $20.5M |
| Q4 2023 | 25 | $6.85M |
| Q3 2023 | 25 | $6.75M |
| Q2 2023 | 27 | $7.44M |
| Q1 2023 | 28 | $7.86M |
| Q4 2022 | 31 | $13.3M |
| Q3 2022 | 30 | $28.4M |
| Q2 2022 | 25 | $25.6M |
| Q1 2022 | 30 | $39.7M |
| Q4 2021 | 26 | $27.0M |
| Q3 2021 | 22 | $49.9M |
| Q2 2021 | 28 | $41.9M |
| Q1 2021 | 33 | $54.6M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Equillium, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Victory Capital Management Inc | 3,325,050 | $12.5M | 0.01% | +154,851+4.9% | Added |
| Vanguard Group Inc | 848,996 | $3.20M | 0.00% | −1,081−0.1% | Reduced |
| Franklin Resources Inc | 700,000 | $2.63M | 0.00% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 615,541 | $2.32M | 0.46% | −122,635−16.6% | Reduced |
| Tang Capital Management LLC | 600,000 | $2.26M | 0.45% | 00.0% | Unchanged |
| Deutsche Bank AG | 356,461 | $1.34M | 0.00% | 00.0% | Unchanged |
| DCF Advisers, LLC | 187,666 | $708.0K | 0.36% | +2,000+1.1% | Added |
| Geode Capital Management, LLC | 154,185 | $578.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 106,200 | $398.0K | 0.01% | 00.0% | Unchanged |
| FMR LLC | 77,800 | $292.0K | 0.00% | −132,000−62.9% | Reduced |
| State Street Corp | 49,656 | $186.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 40,748 | $154.0K | 0.00% | −2,043−4.8% | Reduced |
| Two Sigma Securities, LLC | 40,632 | $153.0K | 0.03% | −43,316−51.6% | Reduced |
| Northern Trust Corp | 32,256 | $122.0K | 0.00% | −1,799−5.3% | Reduced |
| Citadel Advisors LLC | 15,638 | $59.0K | 0.00% | +4,729+43.3% | Added |
| United Capital Financial Advisers, LLC | 13,500 | $51.0K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 10,109 | $38.0K | 0.00% | +10,109 | New |
| Simplex Trading, LLC | 7,119 | $26.0K | 0.00% | +7,119 | New |
| Tower Research Capital LLC (TRC) | 3,476 | $13.0K | 0.00% | +3,476 | New |
| Morgan Stanley | 2,528 | $9.00K | 0.00% | +2,303+1,023.6% | Added |
| BNP Paribas Arbitrage, SA | 1,209 | $4.56K | 0.00% | +1,209 | New |
| Wells Fargo & Company | 1,112 | $4.00K | 0.00% | 00.0% | Unchanged |
| US Bancorp | 494 | $2.00K | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 300 | $1.00K | 0.00% | +300 | New |
| Bank of America Corp | 34 | $0 | 0.00% | +34 | New |
| AdvisorNet Financial, Inc | 19 | $0 | 0.00% | +19 | New |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −14,130−100.0% | Sold out |
| Koshinski Asset Management, Inc. | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −15−100.0% | Sold out |